Cisatracurium Besylate
- Product NDC
- 0703-2045
- 11-digit product format
- 007032045
- Labeler code
- 0703
- Product ID
- 0703-2045_03d8934d-8294-48ae-b46f-a84b0bf44407
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium Besylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA204960
- Marketing category
- ANDA
- Marketing start
- 2018-09-04
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 200 mg/20mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0703-2045 | CISATRACURIUM BESYLATE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | 25 | Legacy NDC | 20241228_c6e6823b-fa28-4da2-b3f4-9ad0f92782ce.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-2045-03 | 00703204503 | 10 CARTON in 1 BOX (0703-2045-03) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE | 10 carton | 2018-09-04 | 0000-00-00 | No | No | Current |